MedPage Today on MSN
Gastric Cancer's Individualized Patient-Centered Treatment Approach
The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...
Hosted on MSN
New methods show how fast breast cancers grow and how surgery delays affect cancer staging
Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how fast breast cancers grow in patients and how ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Daiichi Sankyo and AstraZeneca’s ENHERTU followed by THP showed an improved safety profile versus standard of care First phase 3 trial to demonstrate benefit of ENHERTU in early breast cancer Results ...
“The clinically meaningful improvement in pathologic complete response and the safety data seen in DESTINY-Breast11 highlight the potential of ENHERTU to challenge the current standard of care in ...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)-- Positive results from the DESTINY-Breast11 phase 3 trial showed ENHERTU ® (trastuzumab deruxtecan) followed by paclitaxel, trastuzumab and pertuzumab ...
Keytruda plus chemotherapy improved pathologic complete response and event-free survival in high-risk, early-stage triple-negative breast cancer. Tumor mutational burden and T-cell inflamed 18-gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback